Patient Blood Management in Patients Scheduled for Cardiac Surgery
Recruiting
Observational Study
Anemia
Anemia, Iron-Deficiency
Iron Deficiency Anemia Treatment
Iron Deficiency Anemia (IDA)
Cardiac Surgical Patients
Blood Loss, Surgical
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 464 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- all adult patients scheduled for elective cardiac surgery
Exclusion Criteria:
* pregnancy
* dyalisis
* patient's refusal
Contacts
Luciana Teofili, PhD, MD
+390630151
CONTACT